Although the hypothalamus functions as a master homeostat for many behaviors, little is known about the transcriptional networks that control its development. To investigate this question, we analyzed mice deficient for the Forkhead domain transcription factor Foxd1. Foxd1 is selectively expressed in neuroepithelial cells of the prethalamus and hypothalamus prior to the onset of neurogenesis, and is later restricted to neural progenitors of the prethalamus and anterior hypothalamus. During early stages of neurogenesis, we observed that Foxd1-deficient mice showed reduced expression of Six3 and Vax1 in anterior hypothalamus, but overall patterning of the prethalamus and hypothalamus is unaffected. After neurogenesis is complete, however, a progressive reduction and eventual loss of expression of molecular markers of the suprachiasmatic, paraventricular and periventricular hypothalamic is observed. These findings demonstrate that Foxd1 acts in hypothalamic progenitors to allow sustained expression of a subset of genes selectively expressed in mature neurons of the anterior hypothalamus.
1, Introduction
The hypothalamus is a master regulator of a broad range of homeostatic processes and innate behaviors, including circadian rhythms, sleep, blood pressure, thirst, feeding and body weight, control of the neuroendocrine system, and a range of sexual, emotional and affiliative behaviors Burbridge et al., 2016; Caron and Richard, 2017; Herrera et al., 2017; Lechan and Toni, 2000; Lee et al., 2012; Liu et al., 2017; Morrison, 2016) . Despite its behavioral importance, the development of the hypothalamus is poorly understood, largely because of its considerable anatomic and cellular complexity (Braak & Braak, 1992; Flament-Durand,1980; Lechan & Toni, 2000) . Although recently some progress has been made in identifying extrinsic and intrinsic factors that control hypothalamic patterning and neurogenesis, much remains unknown Burbridge et al., 2016; Xie and Dorsky, 2017) .
Large-scale analysis of gene expression in the developing mouse hypothalamus has provided a starting point for examining hypothalamic development, and has identified candidate genes that are expressed in discrete spatial domains of early hypothalamic neuroepithelium (Shimogori et al., 2010) . Among these genes is the Forkhead domain transcription factor Foxd1. Previously identified as a regulator of kidney and retinal ganglion cell development (Carreres et al., 2011; Hatini et al., 1996) , Foxd1 was observed to be broadly expressed in neural progenitor cells of the prethalamus and anterior and tuberal hypothalamus during early stages of neurogenesis by E11.5 ( Figure  1A,B ). By E14.5, however, Foxd1 expression was no longer detected in anterior or tuberal hypothalamus, and became restricted to prethalamic neuroepithelium ( Figure  1C,D) . Although no hypothalamic defects in Foxd1 mutants have been previously reported (Carreres et al., 2011; Gumbel et al., 2012; Hatini et al., 1996; Levinson et al., 2005) , the spatially and temporally dynamic expression pattern of this gene suggests a potential role in patterning the hypothalamus and/or prethalamus.
In this study, we have investigated the developmental phenotype of Foxd1 mutants using the region-specific markers identified in our previous work (Shimogori et al., 2010) . Despite broad early expression in developing hypothalamus and prethalamus, Foxd1deficient mice show substantially delayed developmental defects that are essentially confined to the anterior hypothalamus. At E12.5, Foxd1-deficient mice exhibit only modest developmental defects. Early markers of anterior hypothalamic structures such as the suprachiasmatic nucleus (SCN) are detected at E16.5, but by birth are either lost entirely or substantially downregulated. Moreover, markers of terminal differentiation of the SCN, as well as other anterior hypothalamic structures such as the periventricular nucleus (PeVN) and paraventricular nucleus (PvN) are also lost by birth. The contrast between the selective expression of Foxd1 in early-stage hypothalamic progenitors, and the delayed appearance of a developmental phenotype, implies that Foxd1 may control anterior hypothalamic development indirectly by regulating expression of additional transcription factors such as Six3 and Vax1. Alternatively, the delayed developmental phenotype in Foxd1 mutants may result from altered chromatin accessibility at cisregulatory sequences required for sustained expression of anterior hypothalamic-enriched genes in terminally differentiated neurons. These findings provide new insight into the transcriptional regulatory networks that specify cell identity in the hypothalamus..
Materials and methods:

Mouse breeding and embryo collection
Heterozygous Foxd1-Cre: GFP knock-in mice (Foxd1-Cre/+) (Humphreys et al., 2008) were mated to each other to generate homozygous animals (Foxd1-Cre/ Foxd1-Cre) that phenocopy null mutations in Foxd1, and are referred to in this manuscript as Foxd1 mutants. Heterozygous Foxd1-Cre/+ animals are used as controls for all experiments. Mice were maintained and euthanized according to protocols approved by Johns Hopkins Institutional Animal Care and Use Committee.
In situ hybridization
Embryos were post-fixed in 4% paraformaldehyde in 1xPBS, then embedded in gelatin before sectioning. In situ hybridization was performed as previously described (Shimogori et al., 2010) .
EdU staining and cell counting
Pregnant dams were injected with 50 mg/kg EdU (20 mg/mL in saline) on embryonic day E12.5 and then sacrificed via cervical dislocation 2 hours later. Embryos were post-fixed in 4% PFA, cryopreserved in 30% sucrose, embedded in OCT then cryostat sectioned. EdU staining was performed using the Click-IT EdU imaging kit from Invitrogen, and then the slides were coverslipped using Vectashield. Stained slides were imaged at 40x on a Keyence microscope. Cell counting was conducted using ImageJ on five to six sections per animal. All counting was done blinded and manually.
TUNEL staining
Post-fixed and cryopreserved E12.5 embryos were sectioned and dry mounted. TUNEL staining was performed according to the protocol for cryopreserved tissue in the In Situ Cell Death Detection Kit-TMR red (Roche). A positive control was used (3000 U/mL DNAse I). Slides were DAPI stained then coverslipped using Vectashield.
Immunohistochemistry
Embryos were harvested and post-fixed in 4% paraformaldehyde in 1xPBS for a minimum of 16 hours at 4°C. Slides were washed 3x5 min in 1xPBS, then cryopreserved in 30% sucrose in 1xPBS for a minimum of 24 hours at 4°C. Embryos were then embedded in OCT blocks on dry ice, and sectioned on a cryostat at 25µm thickness. Sections were immediately dry mounted onto Superfrost Plus slides and allowed to dry before storing at -20°C. Before beginning the procedure, slides were allowed to dry at room temperature, and then marked with a pap pen to isolate the sections. Slides were incubated in blocking buffer (10% HIHS in 0.1% TX-100 in 1xPBS) for at least two hours at room temperature, before incubating in primary antibody in blocking buffer overnight at 4°C.
Antibodies used are as follows: rabbit anti-GFP 1:1000 (Life Technologies A6455 polyclonal) and rat anti-dsRed 1:1000 (Chromotek 5F8 monoclonal). Slides were washed 3x5 min in 1xPBS-T then incubated with secondary antibody in blocking buffer for two hours at room temperature. Secondary antibodies used were goat anti-rabbit-488 and donkey anti-rat-555. The slides were then washed 5 min in 1xPBS-T before DAPI staining in 1:5000 DAPII in 1xPBS-T for 5 min. Slides were then rinsed 3x5 min in 1x-PBS-T before coverslipping in Vectashield. Stained slides were imaged at 10x on a Keyence microscope.
Whole-mount in situ hybridization
All incubations were at room temperature unless otherwise noted, and performed in 24well mesh plates. E9.0 and E10.0 wild-type embryos were harvested in cold 1xPBS-DEPC. E10 embryos were cut down the midline to allow for probe access. Embryos were fixed in 4% PFA in 1xPBS-DEPC for approximately one week. After fixation, the embryos were washed 2x15 min in PTw (1% Tween-20 in 1xPBS-DEPC) then dehydrated with 25%, 50%, then 75% methanol in PTw for 15 min each, then 100% methanol in PTw 3x15 min. Embryos were stored overnight at -20°C, before rehydration in 75%, 50%, and then 25% methanol in PTw for 15 min each, followed by PTw 2x15 min.
Embryos were then incubated in 6% hydrogen peroxide in PTw for 60 min, followed by PTw wash 2x15 min. Embryos were then incubated 3x30 min in detergent mix (1% Igepal CA-630, 1% SDS, 0.5% Na Deoxycholate, 50mM Tris-HCl pH 8.0, 1mM EDTA, 150 mM NaCl) followed by a 10 min PTw wash. Embryos were digested in 10µg/mL Proteinase K in PTw for 20 min, post-fixed in 0.2% glutaraldehyde, 4% PFA in PTw for 20 min, then washed in PTw 2x10 min. A prehybridization step followed, with room temperature hybridization buffer added to the embryos before incubating at 70°C for one hour. Probe was added directly to the vials (25µl per 5mL hybridization buffer) and hybridized overnight at 70°C. Following hybridization, embryos were incubated in Solution X 4x45 min. At this point, the protocol is identical to the high-quality in situ hybridization protocol up to and including adding the antibody. Following antibody incubation, the embryos were washed in 1xTBST 3x10 min, 5x60 min, then overnight. Embryos were washed in NTMT 3x10 min then incubated in an NBT/BCIP color reaction solution at either room temperature or 4°C. Embryos were then washed in 1xTBST to remove the background signal, and the color reaction was stopped in TE.
RNA-Seq analysis
Hypothalamic tissue was dissected at E12.5 and E17.5 as previously described (Shimogori, et al. 2010 ) and stored -80°C prior to use. A total of 8a Foxd1-null and 10 control (either wild-type or Foxd1-Cre +/-) embryos were harvested at E17.5, which were pooled into two samples for each genotype, for an n=2. In the litter dissected at E12.5 there were 5 embryos of each genotype, of which 3 were E12.5 and 2 were E12.0, which were also pooled into two samples for an n=2. After genotyping, the RNA was extracted using the RNeasy kit (Qiagen). RNA from individuals of each genotype were then pooled and sent for quality control analysis to determine concentration and purity via Bioanalyzer. The E12.5 RNA had significant gDNA contamination, so DNAse digestion using the Qiagen kit was performed prior to Bioanalzyer analysis of isolated RNA. A cDNA library was generated and barcoded for each pooled RNA sample, than sequenced to a paired-end read depth of 100 cycles using Illumina HiSeq 2500. The raw RNA-Seq results were mapped onto mm9 genome (NCBI37) using the default parameters in Tophat and Cufflinks (Trapnell et al., 2012) to generate gene expression FPKM (fragments per kilobase of exon per million). Cuffdiff was used to determine differentially expressed genes between the control and mutant samples. Differentially expressed genes with a qvalue of <0.05 were considered significant.
Statistical methods used
For the EdU cell counting, the number of EdU-positive cells was taken as a fraction of the total area of the hypothalamus measured in µm 2 . The values of the sections were averaged for each individual, and then compared using a two-tailed t-test. Two animals were used for each genotype.
Results:
Foxd1 is broadly expressed in neuroepithelial cells of the prethalamus and hypothalamus.
We first sought to expand upon our previous study of Foxd1 expression (Shimogori et al., 2010) by more fully exploring the spatial and temporal expression pattern of Foxd1 in the developing hypothalamus and prethalamus. For these studies, we used a mouse line in which a Cre-GFP fusion had been inserted in frame with the start codon of the endogenous Foxd1 locus (Hatini et al., 1996; Humphreys et al., 2008) , which we then crossed to the Cre-dependent tdTomato reporter line Ai9 (Madisen et al., 2010) . Using this approach, we observed Cre activity as early as E8.5 in the region of the presumptive hypothalamus ( Figure 1E ). Using whole-mount in situ hybridization, Foxd1 mRNA was found to be strongly expressed in prethalamic and hypothalamic neuroepithelium at E9.5 ( Figure 1F ) and E10.5 ( Figure 1G ), as well as in paraxial mesoderm, as previously described (Hatini et al., 1994) . Using immunohistochemistry against GFP in heterozygous Foxd1-Cre-GFP knock-in animals, we found that Foxd1 expression was restricted to hypothalamic and prethalamic neural progenitors at E12.5 ( Figure 1H ), consistent with our previous in situ hybridization analysis (Shimogori et al., 2010) . Analysis of Foxd1-Cre-GFP; Ai9 mice at E12.5, however, revealed that virtually the entirety of both hypothalamic and prethalamic regions expressed tdTomato, demonstrating that these cells arise from Foxd1-expressing progenitors ( Figure 1I-K) . This was the also seen in Foxd1-Cre-GFP; Ai9 mice at P0.5 ( Figure 1L -S), consistent with previous analysis of adult Foxd1-Cre-GFP; Ai9 mice (Salvatierra et al., 2014) .
Foxd1-deficient mice show modest reductions in Six3 and Vax1 expression at E12.5, but no changes in cell proliferation or death.
We generated Foxd1-deficient mice by creating homozygous Foxd1-Cre-GFP/ Foxd1-Cre-GFP mice, which, as previously reported, show no detectable expression of native protein and die neonatal (Hatini et al., 1996) . We first analyzed these mice at E12.5, conducting section in situ hybridization using a panel of markers that label discrete regions within prethalamus and/or hypothalamus ( Figure 2A ) (Shimogori et al., 2010) . Most probes tested, including Isl1, Rax, Sim1, Arx, Lhx1 and Lhx5 ( Figure 2B -M), showed no detectable difference in either expression pattern or signal intensity. In addition, no changes in either proliferation or cell death were observed at this age in Foxd1-deficient embryos (Figure 3 ).
In contrast, expression levels of the transcription factors Six3 (Figure 2N ,O) and Vax1 ( Figure 2P ,Q) showed reduced expression in the ventral hypothalamus of Foxd1-deficient embryos. Six3 also showed reduced expression in its prethalamic expression domain, with a more dramatic reduction observed in the ventricular zone ( Figure 2O ; red arrowhead) than in the mantle zone ( Figure 2O ; black arrowhead).
Foxd1-deficient mice show reduced expression of a subset of anterior hypothalamic markers by E16.5.
At E16.5, we observed selective defects in the expression of molecular markers for individual neuronal populations in the SCN and prethalamus in Foxd1-deficient embryos ( Figure 4A ). Although the broadly-expressed gene Isl1 did not show altered expression ( Figure 4B ,C), we observed a reduction in the expression levels of the SCN markers Rorb (Figure 4D ,E) and Lhx1 (Figure 4F ,G). Expression of somatostatin (Sst) was also disrupted in the thalamic reticular nucleus -a prethalamic structure -but was not detectably altered in lateral hypothalamus ( Figure 4H ,I).
Foxd1-deficient mice show SCN agenesis and severe reduction of a subset of anterior hypothalamic markers by P0.5.
By P0.5, severe defects in SCN, PeVN and PVN differentiation were observed in Foxd1deficient mice. Expression of Lhx1, a master regulator of terminal SCN differentiation Bedont, et al. 2017) , was completely absent ( Figure 5A, B) , as was expression of Vipr2, an essential mediator of circadian entrainment in the SCN (Figure 5C,D) (Harmar et al., 2002) . Rora and Rorb, two selective markers of the SCN and key transcriptional regulators of the core circadian clock, showed substantially reduced expression ( Figure 5E-H) . The histology of the SCN was also severely disrupted, with DAPI staining showing no remaining detectable nuclear organization ( Figure 5I, J) .
Genes that are expressed in SCN, as well as other anterior hypothalamic regions, also showed altered expression. Avp expression in SCN was virtually absent, and was substantially reduced in PVN, although its expression in SON was unaffected ( Figure 5K , L). Expression of Six3, an essential transcriptional regulator of SCN development (VanDunk et al., 2011) , showed dramatically reduced expression in the SCN region, as did the transcription factor Vax1 (Figure 4M-P) . Sst expression was absent from the PeVN and PVN ( Figure 5Q, R) , and expression of the transcription factor Emx2 was likewise absent from the PeVN, but continued to show expression in the subparaventricular zone (vSPZ) ( Figure 5S, T) . Isl1, which is broadly expressed in the prethalamic-derived reticular nucleus, as well as the anterior and tuberal hypothalamus at this age, also showed substantially reduced expression throughout the hypothalamus, although expression in reticular nucleus was unaffected ( Figure 5U , V; Figure 6A , B).
Not all anterior hypothalamic markers showed reduced expression in Foxd1-deficient mice at P0.5, however. Expression of Th in A14 dopaminergic cells of the PeVN was unaffected ( Figure 5Y, Z) , as was Trh expression in the PeVN (Figure 5A', B' ) and the PVN (Figure 6E, F) . Gad67, which is expressed in GABAergic neurons throughout the anterior hypothalamus (O'Hara et al., 1995) , likewise was not affected in Foxd1-deficient mice (Figure 5W, X) . Despite the fact that reduced expression of Six3 was observed in prethalamus at E12.5 ( Figure 2N , O), its expression in thalamic reticular nucleus was unaffected at P0.5 ( Figure 5N, red arrow) . Likewise, no changes in Sst and Isl1 expression were seen in the prethalamus ( Figure 5T, V red arrowhead) , despite the fact that hypothalamic expression of both genes was severely disrupted, and the fact that prethalamic Sst expression was disrupted at E16.5 ( Figure 4G ). Finally, aside from decreased Isl1 expression, no changes in expression of markers of the tuberal and posterior hypothalamus were observed ( Figure 6E-N) .
RNA-Seq analysis identified additional genes showing altered expression in
Foxd1-deficient mice at E12.5 and E17.5.
To further characterize changes in gene expression resulting from loss of function of Foxd1, we conducted RNA-Seq analysis of E12.5 and E17.5 hypothalamus and prethalamus derived from heterozygote controls and Foxd1-deficient mice. At both ages we observed a dramatic downregulation of Foxd1 mRNA levels, as expected, but otherwise saw essentially no other overlap in genes that showed significantly altered expression at E12.5 and E17.5 (q<0.05). We observed 2 genes that were upregulated and 49 genes that were downregulated at E12.5, and 16 genes that were upregulated and 10 that were downregulated at E17.5. Several of the genes upregulated at E17.5 are selectively expressed in telencephalic structures, such as Foxg1, Neurod2 and Tbr1 (Table 2) , which suggest that these might reflect contamination of these samples by telencephalic structures. At E12.5, we also observed substantially reduced expression of Zfhx2 and Zfhx3, two transcription factors selectively expressed in anterior hypothalamus, as well as Six3 (Table 1 ). Other transcriptional regulators that show both reduced expression in Foxd1deficient mice and selective expression in embryonic anterior hypothalamus include the transcription factor Tox2, the histone demethylase Kdm6b, and the transcriptional coregulator Rere (Eichele and Diez-Roux, 2011; Lein et al., 2007) .
With the exception of Pou4f1 and Irx1, which likely represent dissection contaminants from habenula, all of the genes that are significantly downregulated in E17.5 Foxd1deficient mice are selectively expressed in anterior hypothalamus. These include the neurohormones Avp, Oxt and Crh; the transcription factor Vax1, and the cell adhesion molecule Cdh23 (Table 2) .
Discussion
In this study, we have identified Foxd1 as an essential regulator of anterior hypothalamic development. Despite showing strong and selective expression in early hypothalamic and prethalamic neuroepithelial and neural progenitor cells, the effects of loss of function of Foxd1 are initially quite modest at E12.5, and are primarily confined to downregulation of a handful of genes that are selectively expressed in developing anterior hypothalamus, including the transcription factors Six3, Vax1 and Zfhx3. Most anterior hypothalamic markers, and all tuberal and posterior hypothalamic markers tested were unaffected at this age, and only Six3 showed reduced expression in neural progenitors of the prethalamus. At E16.5, when neurogenesis is essentially complete in hypothalamus and prethalamus and Foxd1 expression is barely detectable, we observed reduced expression of early markers of the developing SCN, including Lhx1 and Rorb, along with reduced Sst expression in thalamic reticular nucleus (which is derived from prethalamus). By P0.5, expression of SCN-specific markers is either absent or greatly reduced, and nucleogenesis of the SCN does not occur. In addition, there is a reduction or absence of expression of a subset of PeVN and PVN-specific markers, including Avp and Sst. Although there appears to be disrupted expression of a limited number of prethalamic markers at earlier timepoints, this is no longer observed at P0.5.
These findings lead us to draw several conclusions about the mechanism by which Foxd1 regulates the development of the prethalamus and hypothalamus. First, despite its initially broad expression throughout both structures, and selective expression in anterior hypothalamus following the onset of neurogenesis, Foxd1 is not required for spatial patterning or neurogenesis in either region; no obvious transformations in the identity of individual cell types are observed following Foxd1 loss of function.
Second, the effects of Foxd1 loss of function in hypothalamus primarily reflect a failure to either maintain expression of early-onset cell specific genes or to undergo terminal differentiation. An example of the former is Lhx1, the earliest detectable selective marker of the developing SCN, which initiates expression normally, but which shows reduced and then absent expression at later stages of development. An example of the latter is Sst expression in the PeVN and PVN, which is never initiated. It is, however, likely that failure of terminal differentiation results from disrupted maintenance of expression of master transcriptional regulators, such as Lhx1 itself in the case of the SCN. It is also important to note that in no hypothalamic region examined was there a complete failure of differentiation. Although the SCN was the most severely affected area, cells in this region continued to express the GABAergic marker Gad67, and also showed reduced but still detectable expression of Rora and Rorb. In the PeVN, Sst and Emx2 expression were lost but Th and Trh expression were preserved. Likewise, Avp and Sst expression in the PVN were sharply downregulated but Trh expression was unaffected. Taken together, these data imply that Foxd1 does not regulate cell identity per se, but is instead necessary to maintain expression of a subset of cell type-specific genes in anterior hypothalamus.
Third, despite strong and persistent expression of Foxd1 in prethalamic neuroepithelium, only modest and transient changes in prethalamic markers were observed. Although reduced Six3 and Sst expression were observed in embryonic prethalamus, at P0.5 there were no changes in either the pattern or intensity of prethalamic markers detected. This implies that while Foxd1 may regulate the kinetics of differentiation of certain prethalamic cell types, it is dispensable for their terminal differentiation.
Finally, the discrepancy between the neural progenitor-specific expression pattern of Foxd1 and the late onset of the developmental phenotypes observed in Foxd1 loss-offunction mutants implies that Foxd1 acts indirectly to control expression of genes associated with terminal differentiation. The most obvious mechanism by which this could occur is by regulation of expression of other transcription factors, which in turn go on to guide terminal differentiation of specific neuronal subtypes.
Several potential candidate factors were identified in our analysis, including Six3, Zfhx3 and Vax1. Six3 is expressed broadly in the developing anterior hypothalamus, and is one of the most strongly downregulated genes in Foxd1 mutants, as measured by both RNA-Seq and in situ hybridization. Previous work has shown that Six3 is essential for terminal differentiation of the SCN (VanDunk et al., 2011) . The same study also suggested a possible role in regulating Avp expression in the PVN (VanDunk et al., 2011) . Another gene known to regulate SCN-specific gene expression is the zinc homeodomain factor Zfhx3, which is significantly downregulated in RNA-Seq analysis of E12.5 Foxd1 mutant hypothalamus. Hypomorphic mutations of Zfhx3 have been shown to lead to reduced expression of SCN-specific genes and altered circadian function (Balzani et al., 2016; Parsons et al., 2015; Wilcox et al., 2017) . A final candidate gene is Vax1, also shown to be strongly downregulated as measured by both RNA-Seq and in situ hybridization, which is also expressed in ventral hypothalamus, and has been reported to be required for expression of SCN-specific genes and maintenance of normal circadian activity rhythms (Hoffmann, et al. 2016) .
Foxd1-dependent regulation of Six3, Zfhx3 and Vax1 may thus account for the severe defects in SCN development observed in Foxd1 mutants. It is important to note that expression of these genes is reduced but not eliminated in Foxd1 mutants, implying that additional, as yet unidentified, transcription factors are required to maintain expression of these genes in anterior hypothalamus. Further and more detailed analysis of mice mutant for these genes will be needed to determine whether disruption of these genes also accounts for observed defects in PeVN and PVN.
A second, and not mutually exclusive, potential mechanism of action of Foxd1 might be to prime the activation of cis-regulatory elements that control expression of cell typespecific genes during late stages of differentiation in hypothalamic neural progenitor cells. Other members of the Forkhead family such as Foxa1 are known to possess pioneering activity, or the ability to directly bind to closed chromatin and induce a shift to an open conformation (Lupien et al., 2008; Taube et al., 2010) . It is thus possible that Foxd1 selectively targets enhancer elements that are necessary for transcription of critical transcriptional regulators such as Lhx1 in terminally differentiated neurons, altering their chromatin conformation and rendering them accessible for binding by other cell typespecific transcription factors. Global analysis of chromatin conformation using techniques such as ATAC-Seq (Buenrostro et al., 2013) in Foxd1-deficient hypothalamic progenitors can potentially address this question. We hypothesize that Foxd1 regulates Six3 and Vax1, which in turn may regulate Fezf2 and Olig2. B: The transcription factors known to be involved in development of the SCN. We hypothesize that Foxd1 is controlling SCN development through regulation of Six3 and Vax1. In both the dorsal anterior hypothalamus and the SCN, we hypothesize that Foxd1 is working in conjunction with other, unknown transcription factors, due to the incomplete loss of Six3 and Vax1 in the Foxd1-null animals. Table 1 : RNA-Seq analysis of control and Foxd1-deficient E12 hypothalamus. RNA-Seq analysis of E12 hypothalamus from heterozygote control and Foxd1 mutants. Genes are listed that show significant differential expression and/or were analyzed by in situ hybridization. Two replicates from E12 and E12.5 were combined for this analysis. Differentially expressed genes were determined by q-value<0.05. Transcription factors and coregulators are highlighted in italic. Table 2 : RNA-Seq analysis of control and Foxd1-deficient E17,5 hypothalamus RNA-Seq analysis of E17.5 hypothalamus from heterozygote control and Foxd1 mutants. Genes are listed that show significant differential expression and/or were analyzed by in situ hybridization. Differentially expressed genes were determined by q-value<0.05. Transcription factors and coregulators are highlighted in italic. 
